Atrion Corp logo

Atrion Corp (ATRI)

Delisted
30 Aug 2024
NASDAQ (NGS) NASDAQ (NGS)
$
459. 92
0
0%
$
1.11B Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 459.92
Previous Close
Day Range
459.92 459.92
Year Range
274.98 503.24
Want to track ATRI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

ATRI Chart

Smaller But Mighty: 3 Small-Cap Stocks for Long-Term Dividend Growth

Smaller But Mighty: 3 Small-Cap Stocks for Long-Term Dividend Growth

Generally speaking, small-cap stocks have market capitalizations below $2 billion. They tend to have stronger growth potential over the long run when compared to bigger companies in their respective industries.

Investorplace | 2 years ago
Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs

Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs

Atrion's (ATRI) Q2 EPS drops to 23 cents, down from $3.73 year over year, as merger-related expenses with Nordson hit profits despite strong revenue growth in MPS and fluid delivery segments.

Zacks | 2 years ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / July 28, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Atrion Corporation (NASDAQ: ATRI)'s sale to Nordson Corporation for $460.00 per share in cash. If you are an Atrion shareholder, click here to learn more about your legal rights and options.

Accesswire | 2 years ago

Atrion Corp (ATRI) FAQ

What does "Delisted" mean?

Atrion Corp has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

The last recorded dividend was paid on Jun 14, 2024 in the amount of $2.20 per share.

How long did the company pay dividends?

The company paid dividends for 20 years prior to delisting.

Were there any stock splits?

The last recorded stock split occurred on Dec 03, 1996 with a ratio of 3:2.

What was the last known trading price?

The stock last traded at $459.92 on Aug 30, 2024 before being delisted.

Atrion Corp Profile

- Industry
- Sector
Mr. David A. Battat CEO
NASDAQ (NGS) Exchange
049904105 CUSIP
DE Country
- Employees
- Last Dividend
3 Dec 1996 Last Split
- IPO Date

Overview

Atrion Corporation is a diversified company that specializes in the development, manufacture, and sale of a wide range of products primarily designed for fluid delivery, cardiovascular, and ophthalmic applications. Serving a global market, including the United States, Canada, Europe, and internationally, the company caters to the healthcare sector by providing innovative solutions that enhance patient care in the anesthesia, oncology, cardiology, and ophthalmology fields. Founded in 1944 and headquartered in Allen, Texas, Atrion Corporation continues to uphold a commitment to improving health care practices through its extensive product offerings, leveraging direct sales forces, independent sales representatives, and distributors to reach a varied customer base comprising physicians, hospitals, clinics, and treatment centers, as well as other equipment manufacturers.

Products and Services

  • Fluid Delivery Products:

    Atrion's fluid delivery products include advanced valves designed to precisely fill, hold, and release controlled amounts of fluids or gases. These are vital in various medical procedures such as intubation, intravenous therapy, and catheter applications predominantly found in the anesthesia and oncology sectors. Additionally, they play a critical role in promoting infection control within both hospital and home healthcare environments.

  • Cardiovascular Products:

    The company's cardiovascular product lineup features the Myocardial Protection System (MPS), which is crucial for delivering fluids and medications, mixing critical drugs, and controlling temperature, pressure, and other variables during surgery. Their portfolio also includes cardiac surgery vacuum relief valves, silicone vessel loops for retracting and occluding vessels, inflation devices for balloon catheter dilation and stent deployment, and various products for heart bypass surgery.

  • Ophthalmic Products:

    Atrion offers a range of balloon catheters designed for the treatment of nasolacrimal duct obstruction in both children and adults. These products are instrumental in ophthalmic applications, providing innovative solutions for common eye conditions.

  • Safety and Specialty Products:

    Besides its mainstay products, Atrion manufactures devices for safe needle and scalpel blade containment, contributing to safer healthcare environments. Their product range also extends to inflation systems and valves for marine and aviation safety, components for inflatable survival products and structures, and one-way and two-way pressure relief valves that protect sensitive electronics and other items during transport, covering both medical and non-medical applications.

Contact Information

Address: One Allentown Parkway
Phone: 972 390 9800